BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dvorakova E, Vranac T, Janouskova O, Černilec M, Koren S, Lukan A, Nováková J, Matej R, Holada K, Čurin Šerbec V. Detection of the GPI-anchorless prion protein fragment PrP226* in human brain. BMC Neurol 2013;13:126. [PMID: 24063733 DOI: 10.1186/1471-2377-13-126] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Kovač V, Čurin Šerbec V. Prion Protein: The Molecule of Many Forms and Faces. Int J Mol Sci 2022;23:1232. [PMID: 35163156 DOI: 10.3390/ijms23031232] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Thüne K, Schmitz M, Villar-Piqué A, Altmeppen HC, Schlomm M, Zafar S, Glatzel M, Llorens F, Zerr I. The cellular prion protein and its derived fragments in human prion diseases and their role as potential biomarkers. Expert Rev Mol Diagn 2019;19:1007-18. [PMID: 31512940 DOI: 10.1080/14737159.2019.1667231] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Kovač V, Čurin Šerbec V. Prion Proteins Without the Glycophosphatidylinositol Anchor: Potential Biomarkers in Neurodegenerative Diseases. Biomark Insights 2018;13:1177271918756648. [PMID: 29449775 DOI: 10.1177/1177271918756648] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
4 Kovač V, Zupančič B, Ilc G, Plavec J, Čurin Šerbec V. Truncated prion protein PrP226* - A structural view on its role in amyloid disease. Biochem Biophys Res Commun 2017;484:45-50. [PMID: 28109886 DOI: 10.1016/j.bbrc.2017.01.078] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
5 Kovač V, Hafner-Bratkovič I, Čurin Šerbec V. Anchorless forms of prion protein - Impact of truncation on structure destabilization and prion protein conversion. Biochem Biophys Res Commun 2016;481:1-6. [PMID: 27836542 DOI: 10.1016/j.bbrc.2016.11.036] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
6 Garraud O, Cognasse F, Tissot JD, Chavarin P, Laperche S, Morel P, Lefrère JJ, Pozzetto B, Lozano M, Blumberg N, Osselaer JC. Improving platelet transfusion safety: biomedical and technical considerations. Blood Transfus 2016;14:109-22. [PMID: 26674828 DOI: 10.2450/2015.0042-15] [Cited by in F6Publishing: 22] [Reference Citation Analysis]
7 Race B, Phillips K, Meade-White K, Striebel J, Chesebro B. Increased infectivity of anchorless mouse scrapie prions in transgenic mice overexpressing human prion protein. J Virol 2015;89:6022-32. [PMID: 25810548 DOI: 10.1128/JVI.00362-15] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
8 Lukan A, Černilec M, Vranac T, Popović M, Čurin Šerbec V. Regional distribution of anchorless prion protein, PrP226*, in the human brain. Prion 2014;8:28388. [PMID: 24584121 DOI: 10.4161/pri.28388] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
9 Lukan A, Vranac T, Curin Šerbec V. TSE diagnostics: recent advances in immunoassaying prions. Clin Dev Immunol 2013;2013:360604. [PMID: 23970925 DOI: 10.1155/2013/360604] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]